Projected Income Statement: Photocure ASA

Forecast Balance Sheet: Photocure ASA

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 -285 -256 -260 -294 -239 -169 -157 -160
Change - 10.18% -1.56% -13.08% 18.71% 29.26% 7.1% -1.91%
Announcement Date 2/23/22 2/23/23 2/21/24 2/19/25 2/18/26 - - -
1NOK in Million
Estimates

Cash Flow Forecast: Photocure ASA

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 3.703 3.609 4.056 2.459 20.7 20 14.5 14.5
Change - -2.54% 12.39% -39.37% 742.01% -3.4% -27.5% 0%
Free Cash Flow (FCF) 1 21.99 -5.627 44.25 75.33 17.48 66 11.33 24.33
Change - -125.59% 886.42% 70.23% -76.79% 277.49% -82.83% 114.71%
Announcement Date 2/23/22 2/23/23 2/21/24 2/19/25 2/18/26 - - -
1NOK in Million
Estimates

Forecast Financial Ratios: Photocure ASA

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 5.08% -6.58% 12.44% 10.01% 5.39% 16.05% 10.96% 12.03%
EBIT Margin (%) -1.62% -13.09% 6.23% 4.15% -0.14% 16.76% 6.35% 7.59%
EBT Margin (%) -8.78% -19% 2.18% 1.71% -3.13% 14.94% 4% 5.55%
Net margin (%) -8.57% -19.19% 0.06% -0.98% -0.29% 11.59% 3.15% 4.4%
FCF margin (%) 6.1% -1.5% 9.92% 15.32% 3.28% 10.03% 1.7% 3.38%
FCF / Net Income (%) -71.17% 7.83% 16,573.78% -1,566.09% -1,151.02% 86.46% 53.97% 76.84%

Profitability

        
ROA -3.95% - 0.04% -0.67% - - - -
ROE -6.11% -14.89% 0.06% -0.98% -0.31% 71.85% 9.3% 18.1%

Financial Health

        
Leverage (Debt/EBITDA) - - - - - - - -
Debt / Free cash flow - - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 1.03% 0.96% 0.91% 0.5% 3.89% 3.04% 2.18% 2.01%
CAPEX / EBITDA (%) 20.23% -14.65% 7.31% 5% 72.08% 18.93% 19.86% 16.73%
CAPEX / FCF (%) 16.84% -64.14% 9.17% 3.26% 118.42% 30.3% 127.94% 59.59%

Items per share

        
Cash flow per share 1 - - - - - - - -
Change - - - - - - - -
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 - - - - - 13.38 14.56 15.48
Change - - - - - - 8.9% 6.32%
EPS 1 -1.15 -2.66 0.01 -0.18 -0.06 2.83 0.78 1.16
Change - -131.3% 100.38% -1,900% 66.67% 4,816.67% -72.44% 48.72%
Nbr of stocks (in thousands) 26,960 27,106 27,106 27,106 26,607 26,917 26,917 26,917
Announcement Date 2/23/22 2/23/23 2/21/24 2/19/25 2/18/26 - - -
1NOK
Estimates
2026 *2027 *
P/E 20.3x 73.7x
PBR 4.3x 3.95x
EV / Sales 2.09x 2.09x
Yield - -

EPS & Dividend

Y-o-Y evolution of P/E

Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
56.50NOK
Average target price
79.67NOK
Spread / Average Target
+41.00%

Quarterly revenue - Rate of surprise